Vivimed Labs is currently trading at Rs. 77.00, up by 2.30 points or 3.08% from its previous closing of Rs. 74.70 on the BSE.
The scrip opened at Rs. 76.50 and has touched a high and low of Rs. 80.00 and Rs. 76.35 respectively. So far 42482 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 97.00 on 12-Jan-2016 and a 52 week low of Rs. 46.94 on 25-Aug-2015.
Last one week high and low of the scrip stood at Rs. 80.00 and Rs. 73.60 respectively. The current market cap of the company is Rs. 623.85 crore.
The promoters holding in the company stood at 36.79%, while Institutions and Non-Institutions held 2.62% and 60.59% respectively.
Vivimed Labs has announced the transfer and sale of identified products along with their associated trademarks by its wholly owned subsidiary Company, Klar Sehen. As part of this transaction, Klar Sehen will divert certain products within its portfolio to Ordain Healthcare Global, a subsidiary of Spain based Chemo Espana S.A. The total consideration for the identified product lines is Rs 73 crore.
Further, as part of the transaction, Klar Sehen will provide contract manufacturing services for the diversified products for the buyer for an agreed period of time from its two plants located at Hyderabad and Kolkata.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
